KleverStock

Sunway Healthcare 3Q profit jumps 59% on higher patient load

Published 19 November 2026, 01:39 pm Updated 22 November 2026, 07:30 pm KleverstockEN
Sunway Healthcare 3Q profit jumps 59% on higher patient load

KUALA LUMPUR: Sunway Healthcare Holdings Bhd (SHH) remains positive on its prospects for the financial year ending Dec 31, 2026 (FY26) and beyond, anchored by sustained patient demand, medical tourism growth, and ongoing hospital capacity expansion.

In a filing with Bursa Malaysia, the private healthcare provider said it expects to sustain its operating momentum into the final quarter of 2026 as additional bed capacity is progressively licensed and absorbed, alongside the continued maturation of its newer hospitals.

As at Sept 30, 2026, SHH had 1,994 licensed beds and 277 completed beds available for licensing, bringing total capacity to 2,271 beds. Supported by brownfield expansions at Sunway Medical Centre (SMC) Damansara and SMC Penang—including Phase 3 works at SMC Penang to add 105 beds by the second half of 2028—total capacity is projected to reach approximately 2,400 beds by 2028.

Longer term, greenfield developments in Iskandar Puteri, Seremban Sentral, and Putrajaya are slated to push the group’s hospital network capacity past 3,400 beds by 2032, subject to regulatory approvals and project timelines.

For the third quarter ended Sept 30, 2026 (3Q26), SHH’s net profit surged 59.4% year-on-year (y-o-y) to RM95.17 million from RM59.69 million in 3Q25, lifted by stronger operating earnings and lower net finance costs that outweighed higher depreciation and tax expenses. Basic earnings per share rose to 0.83 sen from 0.52 sen previously.

Quarterly revenue climbed 24.3% y-o-y to RM737.44 million from RM593.13 million, driven primarily by its hospital operations segment, where revenue increased 25.1% to RM723.07 million. Inpatient admissions rose 21% y-o-y to 36,541, lifting the group’s overall bed occupancy rate to 76.7% from 70.6% despite a 20% expansion in licensed beds. Foreign patient revenue edged up 2.2% y-o-y to RM91.2 million, supported by arrivals from Indonesia, China, and Cambodia.

On a quarter-on-quarter (q-o-q) basis, 3Q26 revenue grew 9.6% from RM672.90 million in 2Q26, while net profit rose 21.8% from RM78.16 million. Sequential growth was underpinned by a 12% increase in inpatient admissions, a 7.4% rise in foreign patient revenue from RM84.9 million, and an improvement in bed occupancy from 73% in the preceding quarter. Licensed bed capacity also expanded by 7.5% q-o-q from 1,855 beds following the licensing of 108 beds at SMC Sunway City’s newly opened Tower F.

For the cumulative nine-month period (9M26), net profit jumped 47.8% y-o-y to RM206.66 million from RM139.83 million, while revenue increased 26% to RM2 billion from RM1.59 billion.

Regarding shareholder returns, the board did not propose any new dividend for 3Q26. Earlier in the financial year, the group declared and paid a single-tier interim dividend of 8.24 sen per share amounting to RM100 million on Feb 4, 2026, followed by a single-tier dividend of 0.3 sen per share totalling RM5.24 million to Greenwood Capital Pte Ltd on March 19, 2026.

On the industry front, SHH noted that while the evolving healthcare financing landscape—including the scheduled nationwide rollout of the MediAsas initiative by end-January 2027 and the Diagnosis-Related Group (DRG) payment framework—will increase focus on affordability and cost transparency, insurer discount pressures have shown signs of stabilisation.

"Our latest result demonstrates that the capacity we have added is progressively translating into stronger patient activity and earnings. Importantly, occupancy improved despite the significant increase in licensed beds, while our newer hospitals continued to strengthen their contribution to the Group," Sunway Healthcare Group president Datuk Lau Beng Long said in an accompanying statement.

"As we activate the remaining capacity across our network, our priorities are clear: to drive sustainable utilisation, deepen our specialist capabilities, improve operating productivity and maintain disciplined capital deployment. This will allow us to continue delivering quality care while creating sustainable long-term value," he added.